Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm. Sim&Size® is marked CE.


Mathieu Sanchez
Vincent Costalat

Related articles

Sim&Cure, leading medtech start-up proving unique digital solutions to secure neurovascular treatment of cerebral aneurysm, announces a 3M funding round led by Elaia with IT Translation.

2019.05.23 / 3min read.